Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

4 results about "Dibutyl sebacate" patented technology

Dibutyl sebacate (DBS) is an organic chemical, a dibutyl ester of sebacic acid. Its main use is as a plasticizer in production of plastics, namely cellulose acetate butyrate, cellulose acetate propionate, ethyl cellulose, polyvinyl butyral, polyvinyl chloride, polystyrene, and many synthetic rubbers (especially nitrile rubber and neoprene) and other plastics. It can be used for plastics in use in the food packaging industry, in plastics used for medical devices, and for pharmaceutical applications, e.g. as a plasticizer for film coating of tablets, beads, and granules. It is also used as a lubricant in shaving lotions, and a flavoring additive in non-alcoholic beverages, ice cream, ices, candy, and baked goods. It provides excellent compatibility with a range of plastic materials, superior properties at low temperatures, and good oil resistivity. Its other names include Morflex, Kodaflex, polycizer, Proviplast 1944 and PX 404. Dibutyl sebacate is also used as a desensitizer in Otto fuel II, a torpedo monopropellant.

Gradient flame-retardant explosion suppressant special for high-energy-density ternary lithium battery and preparation method of gradient flame-retardant explosion suppressant

PendingCN121022434ALi-accumulatorsSecondary cells servicing/maintenanceDimethyl methylphosphonateDibutyl sebacate
The invention discloses a special gradient flame-retardant explosion suppressant for a high-energy-density ternary lithium battery, and relates to the technical field of safety protection of new energy batteries, the gradient flame-retardant explosion suppressant comprises the following components by mass: 30% of trimethyl phosphate, 16% of dimethyl methylphosphonate, 13% of triphenyl phosphate, 32% of a solvent, and 9% of a composite stabilizer; the compound stabilizer is prepared from 2, 6-di-tert-butyl-4-methylphenol, diisooctyl adipate and dibutyl sebacate according to the mass ratio of 2 to 1 to 1. The invention also provides a preparation method of the gradient flame-retardant explosion suppressant. Through formula optimization, especially adjustment of the composite stabilizer and reinforcement of a raw material pretreatment process, the explosion suppressant can be stably stored and operated within the range of-40 DEG C to 50 DEG C, the application limitation in extremely cold and high-temperature areas is solved, and the explosion suppressant is suitable for most of extreme temperature environments in the world.
Owner:SUIREN FIRE TECH CO LTD

Novel aqueous dispersion as well as preparation method and application thereof

The invention belongs to the technical field of pharmaceutical adjuvant synthesis, and particularly relates to a novel aqueous dispersion as well as a preparation method and application thereof. The novel aqueous dispersion comprises a film-forming agent, a plasticizer, an emulsifier and a solvent, wherein the film-forming agent is methyl cellulose and ethyl cellulose, the plasticizer is dibutyl sebacate, the emulsifier is ammonium oleate, and the solvent is purified water; the proportions of the methyl cellulose, the ethyl cellulose, the dibutyl sebacate, the ammonium oleate and the purified water in the total mass of the aqueous dispersion are 0.9 to 1.7 percent, 19 percent, 2.3 to 3.4 percent, 1.9 to 2.3 percent and 74 to 76 percent respectively; the solid content of the aqueous dispersion is 23%-26%, the viscosity of a 24.5% aqueous solution is 400-1500 mPa.s, and the pH value is 9.5-11.5. The novel aqueous dispersion disclosed by the invention has the characteristics of excellent performance, good film-forming property, high stability and the like, is convenient to apply, does not need additional auxiliary materials and heat treatment for coating, and more importantly, has an excellent slow-release effect, can realize long-time uniform release of medicines, and meets the slow-release coating requirements of oral medicines.
Owner:HUZHOU ZHANWANG PHARMA

Dosage forms comprising mycophenolic acid and methods of their use

PCT designated stageWO2026143020A1DiseaseDibutyl sebacate
Pharmaceutical formulations comprising mycophenolic acid or pharmaceutically acceptable salts or prodrugs thereof are disclosed. Methods of making the formulations and methods of using them to treat, manage or prevent disease and disorders associated with undesired immune response are also disclosed. The formulations include a core comprising mycophenolic acid, microcrystalline cellulose, povidone, and talc surrounded by a seal coat comprising a polymer, plasticizer and talc which is surrounded by a sustained release layer comprising cellulose, dibutyl sebacate, and talc.
Owner:OKAVA PHARMACEUTICALS INC

Antistatic release film

ActiveUS12686777B2MethylanilineBenzoic acid
An antistatic release film, comprising a substrate layer, an antistatic coating, and a release agent coating. The antistatic coating is located between the release agent coating and the substrate layer; the antistatic coating is obtained by drying a coating liquid; and the coating liquid is composed of the following components in parts by weight: 100 parts of polyurethane resin, 40-60 parts of polyvinyl alcohol, 2-4 parts of sodium octyl sulfate, 1-3 parts of N-ethyl-N—(3-sulfopropyl)-3-methylaniline sodium salt, 8-12 parts of dibutyl sebacate, 40-60 parts of n-butanol, 20-30 parts of isobutyl acetate, 0.8-1.5 parts of hydroxyethyl cellulose, 0.3-0.8 part pf 3-acetylbenzoic acid, 0.2-0.8 part of triethylenetetramine, 0.5-1.2 parts of a silane coupling agent, 0.5-1 part of an antioxidant, and 0.6-2 parts of a leveling agent. The antistatic release film enables the surface resistance of the antistatic coating in the antistatic release film to be almost unchanged after 200 days, thereby improving the performance reliability of the antistatic release film.
Owner:ZHEJIANG OUREN NEW MATERIALS CO LTD